AI takes on aging muscles: new study aims to predict sarcopenia before it strikes
NCT ID NCT07426159
First seen Feb 28, 2026 · Last updated May 16, 2026 · Updated 10 times
Summary
This study is testing whether artificial intelligence can better predict who is at risk for sarcopenia—the age-related loss of muscle mass and strength. Researchers will first analyze data from 3,500 adults to build a risk model, then test a personalized 12-week exercise and nutrition program in 120 people aged 50-70. The goal is to catch muscle decline early and tailor interventions to each person.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SARCOPENIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Sylvan Adams Sport Institute
Tel Aviv, 69978, Israel
Conditions
Explore the condition pages connected to this study.